BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31972790)

  • 21. American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture.
    Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
    Ophthalmology; 2015 Jun; 122(6):1180-6. PubMed ID: 25813452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.
    Bagger M; Andersen MT; Andersen KK; Heegaard S; Andersen MK; Kiilgaard JF
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):438-44. PubMed ID: 25537201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.
    Dogrusöz M; Bagger M; van Duinen SG; Kroes WG; Ruivenkamp CA; Böhringer S; Andersen KK; Luyten GP; Kiilgaard JF; Jager MJ
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):833-842. PubMed ID: 28159971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Outcomes in a Multicenter, Prospective Cohort Evaluating the Prognostic 31-Gene Expression Profile for Cutaneous Melanoma.
    Hsueh EC; DeBloom JR; Lee JH; Sussman JJ; Covington KR; Caruso HG; Quick AP; Cook RW; Slingluff CL; McMasters KM
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34036233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile.
    Harbour JW
    Methods Mol Biol; 2014; 1102():427-40. PubMed ID: 24258991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.
    Field MG; Decatur CL; Kurtenbach S; Gezgin G; van der Velden PA; Jager MJ; Kozak KN; Harbour JW
    Clin Cancer Res; 2016 Mar; 22(5):1234-42. PubMed ID: 26933176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved Staging of Ciliary Body and Choroidal Melanomas Based on Estimation of Tumor Volume and Competing Risk Analyses.
    Stålhammar G; Coupland SE; Ewens KG; Ganguly A; Heimann H; Shields CL; Damato B
    Ophthalmology; 2024 Apr; 131(4):478-491. PubMed ID: 38071620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma.
    Keller J; Schwartz TL; Lizalek JM; Chang ES; Patel AD; Hurley MY; Hsueh EC
    Cancer Med; 2019 May; 8(5):2205-2212. PubMed ID: 30950242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging.
    Wisco OJ; Marson JW; Litchman GH; Brownstone N; Covington KR; Martin BJ; Quick AP; Siegel JJ; Caruso HG; Cook RW; Winkelmann RR; Rigel DS
    Melanoma Res; 2022 Apr; 32(2):98-102. PubMed ID: 35254332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA.
    Seider MI; Mruthyunjaya P
    Retina; 2018 Feb; 38(2):211-219. PubMed ID: 28665870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
    de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
    Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.
    Dillon LD; McPhee M; Davidson RS; Quick AP; Martin B; Covington KR; Zolochevska O; Cook RW; Vetto JT; Jarell AD; Fleming MD
    Curr Med Res Opin; 2022 Aug; 38(8):1267-1274. PubMed ID: 35081854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable Results for Uveal Melanoma-Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis.
    Klufas MA; Itty S; McCannel CA; Glasgow BJ; Moreno C; McCannel TA
    JAMA Ophthalmol; 2015 Sep; 133(9):1073-6. PubMed ID: 26086628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Prognostic Precision in Uveal Melanoma through a Combined Score of Clinical Stage and Molecular Prognostication.
    Stacey AW; Dedania VS; Materin M; Demirci H
    Ocul Oncol Pathol; 2022 Feb; 8(1):35-41. PubMed ID: 35356606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling and regression rate of irradiated uveal melanomas.
    Rao RC; Khan M; Badiyan SN; Harbour JW
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):333-7. PubMed ID: 25856819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal Melanoma.
    Gelmi MC; Bas Z; Malkani K; Ganguly A; Shields CL; Jager MJ
    Ophthalmology; 2022 Apr; 129(4):431-437. PubMed ID: 34793831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma.
    Amaro A; Parodi F; Diedrich K; Angelini G; Götz C; Viaggi S; Maric I; Coviello D; Pistillo MP; Morabito A; Mandalà M; Ghiorzo P; Visconti P; Gualco M; Anselmi L; Puzone R; Lanza F; Mosci C; Raggi F; Bosco MC; Varesio L; Zeschnigk M; Spano L; Queirolo P; Pfeffer U
    JAMA Ophthalmol; 2016 Oct; 134(10):1125-1133. PubMed ID: 27532663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications.
    Correa ZM; Augsburger JJ
    Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):131-5. PubMed ID: 24270974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.